Price
$10.73
Decreased by -6.70%
Dollar volume (20D)
15.35 M
ADR%
3.97
Earnings report date
Apr 30, 2025
Shares float
133.37 M
Shares short
9.72 M [7.29%]
Shares outstanding
283.47 M
Market cap
3.26 B
Beta
1.93
Price/earnings
71.88
20D range
10.71 12.95
50D range
10.71 14.00
200D range
10.71 17.08

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.

The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets.

The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer.

It also offers gamma irradiation systems.

The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.

Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 25, 25 0.21
Decreased by -19.23%
0.20
Increased by +4.01%
Nov 5, 24 0.17
Decreased by -19.05%
0.18
Decreased by -5.56%
Aug 5, 24 0.19
Decreased by -9.52%
0.16
Increased by +18.75%
May 2, 24 0.13
Increased by 0.00%
0.13
Feb 27, 24 0.26
Increased by +4.00%
0.26
Nov 1, 23 0.21
Decreased by -8.70%
0.20
Increased by +5.00%
Aug 3, 23 0.21
Decreased by -22.22%
0.18
Increased by +16.67%
May 3, 23 0.13
Decreased by -40.91%
0.14
Decreased by -7.14%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 290.20 M
Decreased by -6.46%
12.32 M
Decreased by -68.14%
Increased by +4.25%
Decreased by -65.94%
Sep 30, 24 285.47 M
Increased by +8.47%
16.99 M
Increased by +224.36%
Increased by +5.95%
Increased by +214.65%
Jun 30, 24 276.59 M
Increased by +8.35%
8.75 M
Decreased by -62.77%
Increased by +3.16%
Decreased by -65.64%
Mar 31, 24 248.18 M
Increased by +12.51%
6.32 M
Increased by +122.48%
Increased by +2.55%
Increased by +97.75%
Dec 31, 23 310.24 M
Increased by +23.31%
38.68 M
Increased by +112.10%
Increased by +12.47%
Increased by +109.81%
Sep 30, 23 263.18 M
Increased by +5.82%
-13.66 M
Decreased by -154.44%
Decreased by -5.19%
Decreased by -151.45%
Jun 30, 23 255.28 M
Decreased by -4.26%
23.51 M
Decreased by -22.70%
Increased by +9.21%
Decreased by -19.26%
Mar 31, 23 220.59 M
Decreased by -6.83%
2.84 M
Decreased by -90.72%
Increased by +1.29%
Decreased by -90.05%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY